Profile data is unavailable for this security.
About the company
Vivimed Labs Limited is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. Its segments include Speciality Chemicals, Pharma, and Others. It supplies niche molecules and formulations for healthcare, pharmaceuticals and specialty chemical consumers in nearly 50 countries. Its active ingredients are used in home and personal care products, such as hair, oral care and anti-microbial preservatives. It offers industrial care products, such as photo chromic dyes and imaging chemicals. Its presence in active pharmaceutical ingredients, finished dosage formulation and retail branded formulation manufacturing, caters to the inner health of people.
- Revenue in INR (TTM)1.47bn
- Net income in INR-3.17bn
- Incorporated1988
- Employees607.00
- LocationVivimed Labs LtdNorth End, Road No. 2,, Banjara Hills,HYDERABAD 500034IndiaIND
- Phone+91 4 066086608
- Fax+91 4 066086699
- Websitehttps://www.vivimedlabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saroja Pharma Industries India Ltd | -100.00bn | -100.00bn | 234.60m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -9.78 | -- | -6.97 | -- | -- | -- |
| Vilin Bio Med Ltd | -100.00bn | -100.00bn | 251.80m | -- | -- | 2.90 | -- | -- | -- | -- | -- | 6.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9741 | -- | 0.4159 | -- | -4.27 | -- | -72.38 | -- | -- | -- |
| Jupiter Bioscience Ltd | -100.00bn | -100.00bn | 369.03m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.42 | -- | 5.61 | -- | 61.37 | -- | 17.32 | -- | -- | -- | 10.48 | 42.43 | 29.30 | 20.92 | 22.82 | 55.40 | -16.74 |
| Vivimed Labs Ltd | 1.47bn | -3.17bn | 410.42m | 607.00 | -- | -- | -- | 0.2783 | -38.77 | -38.77 | 17.88 | -- | -- | -- | -- | 2,429,737.00 | -- | -5.92 | -- | -8.97 | -62.46 | 33.74 | -214.73 | -14.20 | -- | -6.31 | -- | -- | -21.15 | -30.83 | -385.64 | -- | -- | -- |
| Vineet Laboratories Ltd | 1.37bn | 1.46m | 545.21m | -- | 338.06 | 1.67 | 20.45 | 0.3982 | 0.1749 | 0.1749 | 148.76 | 35.35 | -- | -- | -- | -- | -- | -- | -- | -- | 25.44 | -- | 0.107 | -- | 0.4833 | 0.7313 | 0.565 | -- | -29.06 | -- | -18.00 | -- | -- | -- |
